AEYE

AudioEye, Inc.

65
Fundamentals65/ 100
Valuation50/ 100
Upside potential64/ 100
Risk potential43/ 100

AEYE has the edge over ASTS overall, supported by lower modeled downside.

ASTS

AST SpaceMobile, Inc.

49
Fundamentals66/ 100
Valuation50/ 100
Upside potential65/ 100
Risk potential46/ 100

ASTS offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.

AEYE Fundamentals

MetricStatus
Stable
Under pressure
Strong
Under pressure

AEYE's cash flow is currently strong, and its revenue is stable, but its profitability and balance sheet are under pressure.

ASTS Fundamentals

MetricStatus
Healthy
Weak
Weak
Unavailable

ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.

AEYE PE Valuation

AEYE has no meaningful PE right now: it lost money over the past year.

ASTS PE Valuation

ASTS has no meaningful PE right now: it lost money over the past year.

AEYE Forward outlook

MetricOutlook
--
Strong growth
Growth
Strongly improving
Limited
High

Analysts expect earnings and revenue growth for AEYE, with profitability improving.

ASTS Forward outlook

MetricOutlook
--
Losses growing
Strong growth
--
Limited
Low

Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.

AEYE Risk to reward

ScenarioChangePrice
Upside+76%$25.11
Downside-43%$8.21

Calculated from the latest close: $14.30 on Nov 12.

AEYE trails ASTS on modeled risk to reward, with less potential upside relative to its potential downside.

ASTS Risk to reward

ScenarioChangePrice
Upside+86%$64.16
Downside-46%$18.77

Calculated from the latest close: $34.50 on Nov 12.

ASTS has a better modeled risk to reward balance than AEYE, with more potential upside relative to its potential downside.

AEYE Earnings Per Share

Q4 2023: $-0.50Q1 2024: $-0.40Q2 2024: $-0.29Q3 2024: $-0.28Q4 2024: $-0.36Q1 2025: $-0.41Q2 2025: $-0.35Q3 2025: $-0.29Q4 2025: $-0.25Q1 2026: $-0.30Q2 2026: $-0.37Q3 2026: $-0.25Forward: $1.24
Q4 2023: $-0.50Q1 2024: $-0.40Q2 2024: $-0.29Q3 2024: $-0.28Q4 2024: $-0.36Q1 2025: $-0.41Q2 2025: $-0.35Q3 2025: $-0.29Q4 2025: $-0.25Q1 2026: $-0.30Q2 2026: $-0.37Q3 2026: $-0.25Forward: $1.24
QuarterTTM EPSYoY
Forward$1.24—
Q3 2026-$0.25+$0.04
Q2 2026-$0.37-$0.02
Q1 2026-$0.30+$0.11
Q4 2025-$0.25+$0.11
Q3 2025-$0.29-$0.01
Q2 2025-$0.35-$0.06
Q1 2025-$0.41-$0.01
Q4 2024-$0.36+$0.14

AEYE has the edge over ASTS on earnings, with more consistent year-over-year improvement.

ASTS Earnings Per Share

Q1 2024: $-0.98Q2 2024: $-1.25Q3 2024: $-2.12Q4 2024: $-1.95Q1 2025: $-1.99Q2 2025: $-1.89Q3 2025: $-1.24Q4 2025: $-1.34Q1 2026: $-1.80Q2 2026: $-2.16Q3 2026: $-2.15
Q1 2024: $-0.98Q2 2024: $-1.25Q3 2024: $-2.12Q4 2024: $-1.95Q1 2025: $-1.99Q2 2025: $-1.89Q3 2025: $-1.24Q4 2025: $-1.34Q1 2026: $-1.80Q2 2026: $-2.16Q3 2026: $-2.15
QuarterTTM EPSYoY
Q3 2026-$2.15-$0.91
Q2 2026-$2.16-$0.27
Q1 2026-$1.80+$0.19
Q4 2025-$1.34+$0.61
Q3 2025-$1.24+$0.88
Q2 2025-$1.89-$0.64
Q1 2025-$1.99-$1.01
Q4 2022-$0.58-$0.21

ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.

AEYE Quarterly Revenue

Q4 2023: $8MQ1 2024: $8MQ2 2024: $8MQ3 2024: $9MQ4 2024: $10MQ1 2025: $10MQ2 2025: $10MQ3 2025: $10MQ4 2025: $10MQ1 2026: $11MQ2 2026: $11MQ3 2026: $11M
Q4 2023: $8MQ1 2024: $8MQ2 2024: $8MQ3 2024: $9MQ4 2024: $10MQ1 2025: $10MQ2 2025: $10MQ3 2025: $10MQ4 2025: $10MQ1 2026: $11MQ2 2026: $11MQ3 2026: $11M
QuarterRevenueYoY
Q3 2026$11M+7.2%
Q2 2026$10.7M+8.7%
Q1 2026$10.6M+8.4%
Q4 2025$10.5M+7.9%
Q3 2025$10.2M+15%
Q2 2025$9.9M+16%
Q1 2025$9.7M+20%
Q4 2024$9.7M+24%

AEYE's revenue has grown year over year every quarter since late 2020: $11M last quarter, up 7.2% from the same quarter a year ago.

ASTS Quarterly Revenue

Q4 2023: $0Q1 2024: $500,000Q2 2024: $900,000Q3 2024: $1MQ4 2024: $2MQ1 2025: $718,000Q2 2025: $1MQ3 2025: $15MQ4 2025: $54MQ1 2026: $15MQ2 2026: $32MQ3 2026: $42M
Q4 2023: $0Q1 2024: $500,000Q2 2024: $900,000Q3 2024: $1MQ4 2024: $2MQ1 2025: $718,000Q2 2025: $1MQ3 2025: $15MQ4 2025: $54MQ1 2026: $15MQ2 2026: $32MQ3 2026: $42M
QuarterRevenueYoY
Q3 2026$42.3M+187%
Q2 2026$31.5M+2627%
Q1 2026$14.7M+1952%
Q4 2025$54.3M+2731%
Q3 2025$14.7M+1240%
Q2 2025$1.2M+28%
Q1 2025$718K+44%
Q3 2022$4.2M+70%

ASTS's revenue has grown year over year for 11 quarters in a row: $42M last quarter, up 187% from the same quarter a year ago.

AEYE Free Cash Flow

Q4 2023: $804,000Q1 2024: $146,000Q2 2024: $392,000Q3 2024: $2MQ4 2024: $525,000Q1 2025: −$47,000Q2 2025: $1MQ3 2025: $1MQ4 2025: $3MQ1 2026: $1MQ2 2026: $1MQ3 2026: $2M
Q4 2023: $804,000Q1 2024: $146,000Q2 2024: $392,000Q3 2024: $2MQ4 2024: $525,000Q1 2025: −$47,000Q2 2025: $1MQ3 2025: $1MQ4 2025: $3MQ1 2026: $1MQ2 2026: $1MQ3 2026: $2M
QuarterFree cash flowYoY
Q3 2026$1.7M+67%
Q2 2026$1M-15%
Q1 2026$1.2M+$1.3M
Q4 2025$2.5M+377%
Q3 2025$1M-32%
Q2 2025$1.2M+205%
Q1 2025-$47K-132%
Q4 2024$525K-35%

AEYE has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.

ASTS Free Cash Flow

Q4 2023: −$47MQ1 2024: −$88MQ2 2024: −$38MQ3 2024: −$64MQ4 2024: −$110MQ1 2025: −$149MQ2 2025: −$354MQ3 2025: −$303MQ4 2025: −$331MQ1 2026: −$310MQ2 2026: −$695MQ3 2026: −$464M
Q4 2023: −$47MQ1 2024: −$88MQ2 2024: −$38MQ3 2024: −$64MQ4 2024: −$110MQ1 2025: −$149MQ2 2025: −$354MQ3 2025: −$303MQ4 2025: −$331MQ1 2026: −$310MQ2 2026: −$695MQ3 2026: −$464M
QuarterFree cash flowYoY
Q3 2026-$464.2M-$161.4M
Q2 2026-$694.8M-$341.1M
Q1 2026-$309.7M-$160.7M
Q4 2025-$330.7M-$220.3M
Q3 2025-$302.9M-$239.1M
Q2 2025-$353.6M-$315.3M
Q1 2025-$149M-$61.3M
Q4 2024-$110.5M-$63.2M

ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.

AEYE Total Shares

Q4 2023: 12MQ1 2024: 12MQ2 2024: 12MQ4 2024: 12MQ1 2025: 12MQ2 2025: 12MQ3 2025: 12MQ4 2025: 12MQ1 2026: 12MQ2 2026: 12MQ3 2026: 13M
Q4 2023: 12MQ1 2024: 12MQ2 2024: 12MQ4 2024: 12MQ1 2025: 12MQ2 2025: 12MQ3 2025: 12MQ4 2025: 12MQ1 2026: 12MQ2 2026: 12MQ3 2026: 13M
PeriodChange %Net change
Quarterly+3.9%+482K shares
1 year+4.5%+557K shares
3 years+11%+1.2M shares
5 years+45%+4M shares

AEYE has the edge over ASTS on shareholder dilution, with a more favorable share count trend.

ASTS Total Shares

Q4 2023: 90MQ1 2024: 121MQ2 2024: 141MQ3 2024: 156MQ4 2024: 199MQ1 2025: 224MQ2 2025: 242MQ3 2025: 273MQ4 2025: 256MQ1 2026: 291MQ2 2026: 299MQ3 2026: 300M
Q4 2023: 90MQ1 2024: 121MQ2 2024: 141MQ3 2024: 156MQ4 2024: 199MQ1 2025: 224MQ2 2025: 242MQ3 2025: 273MQ4 2025: 256MQ1 2026: 291MQ2 2026: 299MQ3 2026: 300M
PeriodChange %Net change
Quarterly+0.4%+1.1M shares
1 year+10%+27.3M shares
3 years+235%+211M shares
5 years+480%+248M shares
Available history+944%+271M shares

ASTS has 300M diluted shares, up 10% from a year ago.

AEYE Net Leverage

Q2 2025: 94.8xQ3 2025: 7.9xQ4 2025: 4.4xQ1 2026: 7.8xQ2 2026: 29.1xQ3 2026: 3.7x
Q2 2025: 94.8xQ3 2025: 7.9xQ4 2025: 4.4xQ1 2026: 7.8xQ2 2026: 29.1xQ3 2026: 3.7x
QuarterNet LeverageStatus
Q3 20263.7xElevated
Q2 202629.1xHigh
Q1 20267.8xHigh
Q4 20254.4xHigh
Q3 20257.9xHigh
Q2 202594.8xHigh

AEYE's net debt is about 3.7 years of its operating earnings (EBITDA), down from 7.9 years a year ago.

ASTS Net Leverage

ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

AEYE Weekly Momentum

MetricValueStatus
RSI74.2Overbought
Stochastic84.2Overbought

AEYE's weekly RSI is 74 (overbought) and its Stochastic is 84 (overbought).

ASTS Weekly Momentum

MetricValueStatus
RSI34.1Neutral
Stochastic11.9Oversold

ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).

AEYE PE vs Technology Sector

AEYE has no meaningful PE right now: it lost money over the past year.

ASTS PE vs Technology Sector

ASTS has no meaningful PE right now: it lost money over the past year.

AEYE Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$9.3952% above
20 week MA$7.9081% above
50 week MA$7.8981% above
100 week MA$10.635% above
200 week MA$11.030% above

AEYE has the edge over ASTS on trend strength, trading above more of its moving averages.

ASTS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$44.923% below
20 week MA$57.140% below
50 week MA$75.554% below
100 week MA$57.840% below
200 week MA$33.62.8% above

ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.

AEYE Yearly ROI

YearStart priceEnd priceROI
2020$4.75$26.2+452%
2021$26.2$7.00-73%
2022$7.00$3.85-45%
2023$3.85$5.42+41%
2024$5.42$16.1+197%
2025$16.1$10.7-34%
2026 YTD$10.7$14.3+34%

AEYE has the edge over ASTS on returns for 2026, with the stronger performance.

ASTS Yearly ROI

YearStart priceEnd priceROI
2020$9.87$13.4+36%
2021$13.4$8.71-35%
2022$8.71$3.97-54%
2023$3.97$6.03+52%
2024$6.03$22.9+280%
2025$22.9$72.0+214%
2026 YTD$72.0$34.5-52%

ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.

Give your agent the market.

Get API key